Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M108Revenue (TTM) $M43.8Net Margin (%)-93.6Altman Z-Score-6.2
Enterprise Value $M92.4EPS (TTM) $-0.8Operating Margin %-86.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-93.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-50.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-281.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M54.1ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BDSI is held by these investors:



BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ODONNELL FRANCIS E JRDirector 2017-02-17Sell129,860$1.91-1.57view
Vasisht NirajSee Remarks 2017-01-30Sell6,905$1.91-1.57view
SEARS SAMUEL P JRDirector 2016-12-01Sell12,000$1.6712.57view
Feinberg Barry IDirector 2016-11-23Buy2,000$1.6712.57view
Feinberg Barry IDirector 2016-11-17Buy3,000$1.870.53view
ODONNELL FRANCIS E JRDirector 2016-09-23Sell100,000$2.57-26.85view
Vasisht NirajChief Technology Officer 2016-09-23Sell47,000$2.43-22.63view
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2016-09-22Sell14,800$2.44-22.95view
Feinberg Barry IDirector 2016-08-25Buy2,500$2.55-26.27view
STONE WILLIAM BDirector 2016-08-11Sell16,000$2.57-26.85view

Quarterly/Annual Reports about BDSI:

News about BDSI:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc and H Feb 02 2014 
Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
BioDelivery Sciences International Inc. Reports Operating Results (10-K/A) Nov 19 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,022 Shares Jun 10 2010 
BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,450 Shares May 24 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) May 10 2010 
Weekly CEO Buys Highlight: Saul Centers Inc, Trans World Entertainment Corp, NorthWestern Corp, Nort Apr 05 2010 

More From Other Websites
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive... Feb 27 2017
BioDelivery Sciences Secures Debt Financing with CRG Feb 23 2017
Belbuca return expected to push BDSI to profitability sooner Feb 01 2017
Zacks.com featured highlights: D.R. Horton, FleetCor Technologies, MarketAxess Holdings, Maxim... Jan 31 2017
BioDelivery Sciences to Hold Analyst and Investor Day to Discuss BELBUCA® Commercialization Plans... Jan 26 2017
Is BioDelivery Sciences (BDSI) a Great Growth Stock? Jan 17 2017
MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI) Jan 13 2017
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Jan 09 2017
BioDelivery Sciences Closes Transaction to Reacquire License to BELBUCA® from Endo Pharmaceuticals Jan 09 2017
Is the Options Market Predicting a Spike in BioDelivery (BDSI) Stock? Jan 04 2017
Endo International Is Top 'Dog of the S&P 500' Dec 30 2016
BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business... Dec 14 2016
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive... Dec 13 2016
BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial... Dec 13 2016
BioDelivery Sciences International, Inc. (BDSI): How It Stacks Up Against Its Peers Dec 12 2016
Endo (ENDP) Inks Deal to Return Belbuca Rights to BioDelivery Dec 09 2016
After Endo, global plans for BDSI’s Belbuca? Dec 09 2016
BioDelivery Reacquires Rights for Opioid Painkiller Dec 08 2016
ETFs with exposure to BioDelivery Sciences International, Inc. : December 8, 2016 Dec 08 2016
Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure Dec 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)